Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2007
10/24/2007CN100344624C Pharmaceutical preparations containing arginine amides
10/24/2007CN100344618C N-benzyl acryloyl substituted tyrosine derivatives as hPPAR alpha and hPPAR gamma agonist
10/24/2007CN100344616C Compounds for the treatment of metabolic disorders
10/24/2007CN100344611C 4-nitro-2-[(4'-methoxyl)-phenoxy]-toluenesulfonamide derivant and its medical uses
10/24/2007CN100344610C Aryl-carbaldehyde oxime derivatives and their use as estrogenic agents
10/24/2007CN100344605C Preparation method of 3-fluoro-5-nitro trifluor toluene
10/24/2007CN100344362C Fine particles, method and device for preparation thereof, and agent for parenteral injection and method for production thereof
10/24/2007CN100344328C Capsules containing aqueous fill compositions stabilized with derivatized cyclodextrin
10/24/2007CN100344326C Iron-supplementing preparation
10/24/2007CN100344303C Wet pad for treating piles
10/24/2007CN100344297C Photocatalyst anti-inflammation antibacterial medicinal ointment and its preparation method
10/24/2007CN100344295C Ganoderma lucidum capsule of lycopene
10/24/2007CN100344292C Injection for treating facial tic
10/24/2007CN100344291C Nutritive lead discharging oral liquid and its preparation method
10/24/2007CN100344290C Breviscapine dispersing tablet and its prepn
10/24/2007CN100344289C Pollen pini soft capsule and its preparation method
10/24/2007CN100344288C Compound pain-stopping and inflammation-diminishing anticarcinogen capsule
10/24/2007CN100344287C Biodegradable polyester fluorouracil microglobule and its preparation method
10/24/2007CN100344286C Slow controlled released combsn. preparation of semisolid framework of containing glipizide
10/24/2007CN100344285C Water soluble preparation of domperidone and production thereof
10/24/2007CN100344284C Use of Abidol in preparing medicines for treating and preventing SARS virus
10/24/2007CN100344283C Abidor inclusion compound
10/24/2007CN100344282C Method for preparing rifamicina injecta
10/24/2007CN100344280C 3-hydroxy butanoic acid and novel use of derivative thereof
10/24/2007CN100344279C Application of schisanhenol for preparing medicine for treating ischemic brain apoplexy
10/24/2007CN100344278C Lasofoxifene tablet and its coating
10/24/2007CN100344277C Nano-magnetic medicinal microglobule, its preparation method and application
10/24/2007CN100344238C Method for producing sugar-reducing soluble granules richly containing alpha-linolenic acid, lecithin and trivalent chromium
10/24/2007CN100344234C Pesticidal formulation
10/24/2007CA2586236A1 Compositions comprising co-precipitate of eplerenone and a water-soluble excipient
10/23/2007USRE39892 Pessaries or vaginal tablets of two layers of lactobacilli brevis and salivarius, in bound form, so that the release velocity of bacteria of the outermost layer is greater than the release velocity of bacteria of the innermost layer.
10/23/2007US7285683 Bicyclic and tricyclic cannabinoids
10/23/2007US7285682 Terphenyl guanidines as β-secretase inhibitors
10/23/2007US7285681 Biguanide derivatives
10/23/2007US7285676 Synthesis of chiral 2-alkyl amino acids
10/23/2007US7285670 4,5-Dihydro-2-(2,4-dihydroxyphenyl)-4-methyl-thiazole-4(S)-carboxylic acid by coupling a mono- or polyalkoxybenzonitrile with a cysteine ester and alkylating the thiazoline ring at the 4-carbon position; preferably a phase transfer agent such as N-9-anthracenylmethylcinchonidinium chloride is used
10/23/2007US7285669 Reacting bromine with an aqueous solution of 4-acetamidocyclohexanone to produce 2-bromo-4-acetamidocyclohexanone; adding thiourea to produce 6-acetylamino-2-amino-4,5,6,7-tetrahydrobenzothiazole; and cleaving the acetyl group with hydrobromic acid
10/23/2007US7285668 At a concentration of 0.1-0.5 g/ml. at 0-35 degrees C. from a C1-4 alkyl acetate solution; preservation stability
10/23/2007US7285664 Heterocyclic or benzenic derivatives of lipoic acid, their preparation and their use as medicaments
10/23/2007US7285662 Therapeutic heterocyclic compounds
10/23/2007US7285660 Process for the preparation of L-ribavirin
10/23/2007US7285659 Process for the preparation of D-ribavirin
10/23/2007US7285658 For the treatment of viral infections, microbial infections, and proliferative disorders; contain di- or triphosphate moeity mimetics, such as those containing boron anions
10/23/2007US7285642 Composition and method for modulating dendritic cell-T cell interaction
10/23/2007US7285622 Hydrophilic polymer covalently yet reversibly linked to a amine-containing ligand through a dithiobenzyl linkage; modification of various substrates, such as polypeptides
10/23/2007US7285574 Methods for treating neural cell swelling
10/23/2007US7285573 Use of creatine or creatine analogs for the treatment of diseases of the nervous system
10/23/2007US7285572 Compounds as for example, 2'-[1-[(2R)-3-[[1-(3-fluoro-4-methylphenyl)-2-methylpropan-2-yl]amino]-2-hydroxypropoxy]ethyl]-3-methylbiphenyl-4-carboxylic acid, having a calcium-sensing receptor antagonistic action; therapeutic drug for osteoporosis
10/23/2007US7285571 Herbal chemical composition for the treatment of cancer
10/23/2007US7285570 Compositions and methods for regulating mammalian keratinous tissue
10/23/2007US7285569 Tricycles, their manufacture and use as pharmaceutical agents
10/23/2007US7285568 Substituted p-(2-alkoxy-2-acylethyl)biphenyl compounds, e.g., 1-[4'-(2-ethoxy-3-morpholin-4-yl-3-oxopropyl)biphenyl-3-yl]-3-heptyl-1-methylurea; useful in human or veterinary medicine: dermatology, cardiovascular diseases, immune diseases, and diseases associated with lipid metabolism
10/23/2007US7285567 Halogenated benzamide derivatives
10/23/2007US7285566 Enzyme inhibitor for treating HIV infections in mammals; viricides; patient is suffering from a multi-drug resistant HIV infection; AIDS therapy
10/23/2007US7285565 E.g., 3-(2-(4-[(2-aminosulfonyl)phenyl]benzoylamino)phenoxy)benzamidine; 7-(2-(4-[(2-aminosulfonyl)phenyl]benzoylamino)-4-trifluoromethylphenoxy)1-aminoisoquinoline; and 3-hydroxycarbonyl-2-(4-[(2-aminosulfonyl)phenyl]phenylcarbonylamino)phenoxynaphthalene; highly selective
10/23/2007US7285564 Muscarinic M2 receptor antagonists; such as 4-{N-[7-(3-1-carbamoyl-1,1-diphenylmethyl)pyrrolidin-1-yl)hept-1-yl]-N-(isopropyl)amino}-1-(4-methoxypyrid-3-ylmethyl)piperidine; reduced blurred vision, constipation and dry mouth side effects
10/23/2007US7285563 e.g. N-Benzyl-N'-isoquinolin-5-ylurea; treatment of pain and other conditions ameliorated by the modulation of the function of the vanilloid-1 receptor (VR1)
10/23/2007US7285562 Derivatives of 2-mercaptobenzothiazole, 2-mercaptobenzoxazole, 2-mercaptothiazolo[5,4-b]pyridine, or 2-mercaptooxazolo[5,4-b]pyridine; cardiovascular disorders, diabetes, cancer and obesity
10/23/2007US7285561 Imidazo-substituted compounds as p38 kinase inhibitors
10/23/2007US7285560 E.g., N-[(S)-2-diphenylamino-1-(5-oxo-4,5-dihydro[1,3,4]oxadizol-2-yl)ethyl]-2-(2-methylaminopyrimidin-4-yl)-1H-indole-5-carboxamide; used for treating rheumatoid arthritis, osteoarthritis, asthma, cardiac infarction, Alzheimer's diseases, cancer diseases or atherosclerosis
10/23/2007US7285559 Imidazo-substituted pyrido[2,3-d]pyrimidinylamines; treating arthritis, Crohn's disease, Alzheimer's disease, irritable bowel syndrome, adult respiratory distress syndrome, and chronic obstructive pulmonary disease.
10/23/2007US7285558 Helicobacter infections; bactericides
10/23/2007US7285557 For therapy of obesity, diabetes, depression, or anxiety in a mammal
10/23/2007US7285556 Antiproliferative agents; hematologic, nervous system, autoimmune diseases; osteoporosis, viral infections
10/23/2007US7285555 Promoting microtube polymerization; drug resistanct cancer
10/23/2007US7285554 Pyrazole derivative
10/23/2007US7285553 Serotonergic 5HT7 receptor compounds for treating ocular and CNS disorders
10/23/2007US7285552 For prevention and/or treatment for HIV infection or AIDS induced by the infection
10/23/2007US7285551 For use as therapeutic agent and prophylactic agent for hepatitis C
10/23/2007US7285550 Triazolotriazines and pyrazolotriazines and methods of making and using the same
10/23/2007US7285549 Sulfamides and their use as endothelin receptor antagonists
10/23/2007US7285548 Urea substituted benzothiazoles
10/23/2007US7285547 E.g., N'-hydroxy-3-((1-((2-methyl-1-piperidinyl)carbonyl)-2-(2 -naphthylsulfonyl)hydrazino)methyl)benzenecarboximidamide
10/23/2007US7285546 Cephalotaxanes, their method of preparation and their use in treatment of cancers, leukemias, parasites including those resistant to usual chemotherapeutic agents and as reversal agents
10/23/2007US7285545 N-Pyridyl-7-substituted-2-indolecarboxamides, e.g., 1-Methyl-7-[2-(4-methyl-piperazin-1-yl)-pyrimidin-4-yloxy]-1H-indole-2-carboxylic acid (2-tert-butyl-5-methoxy-pyridin-4-yl)-amide; used to treat chronic inflammatory diseases
10/23/2007US7285544 Administering a nitroxide-containing compound, e.g., Tempol, to treat and alleviate inflammatory skin disorders, e.g., rosacea, atopic dermatitis, contact dermatitis, a drug eruption, psoriasis, seborrheic dermatitis, a connective tissue disease, an autoimmune disorders, urticaria or hives, or infection
10/23/2007US7285543 Purine inhibitors of fructose-1,6-bisphosphatase
10/23/2007US7285541 Antisense treatments for melanoma by inhibition of clusterin, also known as testosterone-repressed prostate message-2, for example by administration of antisense oligonucleotides specific for clusterin
10/23/2007US7285540 hepatocyte growth factor gene as drug; topical applying ; side effect reduction; cardiovascular disorders
10/23/2007US7285538 Gene therapy; mutant Dna
10/23/2007US7285537 Oligonucleotide therapeutic agent and methods of making same
10/23/2007US7285536 Blocking cytokine, chemokines using oligosaccharides
10/23/2007US7285535 Administering TIRAP to block Toll/Interleukin-1 Receptor Adaptor Protein signaling in a cell; for treatment of inflammation and inducing or affecting immune response.
10/23/2007US7285533 Using cytokine agent to induce apoptosis in tissues demonatrating abnormal cell proliferation; antitumor agents; tissue targeted therapy
10/23/2007US7285527 Tumor radiosensitization using gene therapy
10/23/2007US7285525 Suppression of immune response via inhibition of cathepsin S
10/23/2007US7285517 Warming and nonirritating lubricant compositions and method of comparing irritation
10/23/2007US7285383 Cell with recombinant nucleic acid comprisinga hepatitis C virus internal ribosome etry site (IRES) operably linked to a polynucleotide encoding a reporter protein; and a test compound; drug screening for viricides; determining if translation is allowed or prevented by interaction with drug or cell
10/23/2007US7285298 Use of a dihydrochalcone-rich phenolic fraction in a cosmetic treatment
10/23/2007US7285297 Method of reducing low density liproprotein cholesterol concentration
10/23/2007US7285293 Isolating modulators of amyloid expression; obtain plant, extract proteins, incubate with chromatographic column, elute, recover preferential protein
10/23/2007US7285292 Adding an EDTA/NaOH mixture to acontainer and subsequently adding at least one metal compound; adding Na2SeO3 to the container to obtain the trace element solution; improve the trace mineral status of an animal
10/23/2007US7285290 Hydrophilized powder and a composition comprising the same
10/23/2007US7285279 Method of treating malignancies and viral infections and improving immune function with a dietary supplement
10/23/2007US7285276 Polynucleotide sequence for Chlamydia pneumonia; therapy, prevention of Chlamydia infections
10/23/2007US7285266 Cell-polymer fiber compositions and uses thereof
10/23/2007CA2478971C Androstenones
10/23/2007CA2449679C Androstenones
10/23/2007CA2406849C Stabilized liquid preparation
10/23/2007CA2384433C Novel betulinic acid derivatives having antiangiogenic activity, processes for producing such derivatives and their use for treating tumor associated angiogenesis
1 ... 3536 3537 3538 3539 3540 3541 3542 3543 3544 3545 3546 3547 3548 3549 3550 3551 3552 3553 3554 3555 3556 ... 7860